Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

S1613, A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (mCRC) With HER-2 Amplification

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03365882
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:27.521997+00:00
Published At
2024-02-07T00:00:00+00:00
Record Updated At
2026-02-10
Results Posted At
2024-02-07
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Colon Adenocarcinoma", "ERBB2 Gene Amplification", "Rectal Adenocarcinoma", "Recurrent Colon Carcinoma", "Recurrent Rectal Carcinoma", "Stage III Colon Cancer AJCC v7", "Stage III Rectal Cancer AJCC v7", "Stage IIIA Colon Cancer AJCC v7", "Stage IIIA Rectal Cancer AJCC v7", "Stage IIIB Colon Cancer AJCC v7", "Stage IIIB Rectal Cancer AJCC v7", "Stage IIIC Colon Cancer AJCC v7", "Stage IIIC Rectal Cancer AJCC v7", "Stage IV Colon Cancer AJCC v7", "Stage IV Rectal Cancer AJCC v7", "Stage IVA Colon Cancer AJCC v7", "Stage IVA Rectal Cancer AJCC v7", "Stage IVB Colon Cancer AJCC v7", "Stage IVB Rectal Cancer AJCC v7"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-10"
protocolSection.identificationModule.nctId
"NCT03365882"
protocolSection.identificationModule.officialTitle
"S1613, A Randomized Phase II Study of Trastuzumab and Pertuzumab (TP) Compared to Cetuximab and Irinotecan (CETIRI) in Advanced/Metastatic Colorectal Cancer (mCRC) With HER-2 Amplification"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2024-02-07"

Study condition terms

  • Colon Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • ERBB2 Gene Amplification (protocolSection.conditionsModule.conditions)
  • Rectal Adenocarcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Colon Carcinoma (protocolSection.conditionsModule.conditions)
  • Recurrent Rectal Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage III Colon Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage III Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Colon Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Colon Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Colon Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Colon Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IV Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Colon Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVA Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Colon Cancer AJCC v7 (protocolSection.conditionsModule.conditions)
  • Stage IVB Rectal Cancer AJCC v7 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.